Related Experiment Video

Updated: Oct 17, 2025

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
07:03

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

2.3K

Mesenchymal Stem Cell-Derived Extracellular Vesicles with High PD-L1 Expression for Autoimmune Diseases Treatment

Fang Xu1, Ziying Fei1, Huaxing Dai1

  • 1Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China.

Advanced Materials (Deerfield Beach, Fla.)
|October 6, 2021
PubMed

Insights

Engineered extracellular vesicles carrying PD-L1 (MSC-sEVs-PD-L1) show promise for treating autoimmune diseases. These vesicles effectively reconfigure the local immune microenvironment, reducing inflammation in preclinical models of ulcerative colitis and psoriasis.

Area of Science:

  • Immunology
  • Biotechnology
  • Regenerative Medicine

Background:

  • Autoimmune diseases significantly impact patient quality of life.
  • Current treatments often have limitations in efficacy or side effects.

Purpose of the Study:

  • To develop a novel therapeutic strategy for autoimmune diseases.
  • To investigate the potential of engineered extracellular vesicles for immune modulation.

Main Methods:

  • Programmed cell death-ligand 1 (PD-L1) was stably expressed on mesenchymal stem cell-derived extracellular vesicles (MSC-sEVs) via lentivirus-mediated gene transfection.
  • The therapeutic efficacy of MSC-sEVs-PD-L1 was evaluated in mouse models of ulcerative colitis (UC) and psoriasis.

Main Results:

  • MSC-sEVs-PD-L1 demonstrated potent immunosuppressive effects on activated immune cells in vitro.
  • Engineered vesicles showed enhanced accumulation in inflamed tissues compared to parental cells.
  • Significant therapeutic benefits were observed in both UC and psoriasis mouse models, indicating successful reshaping of the local immune microenvironment.

Conclusions:

  • MSC-sEVs-PD-L1 represent a promising cell-free therapeutic platform for autoimmune diseases.
  • This approach offers a novel strategy for targeted immune modulation with high clinical potential.
Keywords:
PD-L1autoimmune diseaseextracellular vesicletargeting

More Related Videos

Setting a Successful Sorting for Extracellular Vesicle Isolation08:37

Setting a Successful Sorting for Extracellular Vesicle Isolation

Published on: October 11, 2024

1.3K
Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs04:54

Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs

Published on: May 3, 2024

891

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K